The fact that EGFR inhibitors could be helpful in the treatment of AD seems to be in contrast with the role of this receptor in neurodegenerative disease since in PD and in other studies regarding AD, EGFR-altered signaling could contribute to neurodegeneration. This evidence concerns the gene EGFR and Parkinson disease.